Scottish Water Reduces Energy Consumption by 60% and Cuts Greenhouse Gas Emissions with Sustainable Water Technology
7.12.2023 14:05:00 CET | Business Wire | Press Release
Scottish Water has made a big dent in its greenhouse gas emissions by deploying advanced technology at 200 pumping stations across its network. By combining high-efficiency pumps and advanced digital technologies, the utility has reduced energy consumption by up to 60%, accelerating its goal of becoming carbon neutral by 2040.
As Scotland's publicly owned water supplier, Scottish Water provides essential water and wastewater services to more than 2.6 million homes and 150,000 business premises across Scotland. Its pump stations move water across a large geography, including remote villages and islands, so the utility was challenged to keep energy consumption and emissions down.
In collaboration with leading global water technology company Xylem (NYSE: XYL), Scottish Water began trialing a smart pumping solution at two pilot sites, Maple Grove and Cross Dene. The trial delivered pronounced cost savings, including a 99% reduction in unplanned maintenance and a 40% reduction in energy, prompting the utility to adopt the technology across its network.
“Moving and treating wastewater is incredibly energy intensive. Around 17% of transport emissions in Scotland are from the water and wastewater operations sector, so anything we can do will have a big impact for both Scottish Water and the country,” Nathan Wield, Wastewater Operations West Manager for Scottish Water, said. “By deploying smart technology, we can prolong the lifetime of our equipment, prevent callouts, and reduce downtime, so there is less service disruption and reduced risk of environmental impact. This delivers real cost savings for the Scottish people and gives us a major boost in our work to reduce our impact on the climate.”
A pioneer of digital innovation, Scottish Water combined several Xylem technologies – Avensor monitoring and Flygt Concertor intelligent pumps – to deliver the cost and energy savings. The utility now has real-time visibility and control across its network. Remote monitoring has enabled the Scottish Water team to replace weekly callouts with monthly inspections.
As a result, the utility saved more than 400,000 miles of reactive travel and 37,000 liters in diesel consumption, reducing its annual carbon output by 160 tCO2e.
“Reducing greenhouse gas emissions across the water sector presents a unique opportunity to rethink water management. New approaches and advanced technologies can help water utilities go further, faster,” Ian Thompson, Xylem Vice President UK & Ireland, said. “Innovative utilities like Scottish Water are a prime example of what can be achieved by harnessing the power of digital to decrease the sector’s impact on the environment – and still deliver a resilient, cost-effective, and reliable service for communities.”
Scottish Water also deployed advanced monitoring systems to extend the life of critical assets, including a main pipeline that runs more than 10 miles from the Blairlinnans Water Treatment Works to a reservoir in West Dunbartonshire. Using Xylem’s SoundPrint Acoustic Fibre Optic System – the first of its kind in Europe – Scottish Water carried out extensive inspections of the pipeline, allowing the utility to reduce the possibility of failure by proactively maintaining areas found to be at risk.
Data from the inspection showed that only 2% of the pipeline needed maintenance attention. Scottish Water achieved significant cost savings by extending the life of the remaining pipe sections resulting in fewer disruptions to customers. That approach to monitoring and targeted maintenance also further reduced the utility’s greenhouse gas footprint by avoiding emissions associated with unnecessary pipeline replacements.
Meet the people involved in accelerating Scottish Water’s journey to net zero emissions by 2040: Technology powers Scottish Water's emission reduction journey, transforming pumping stations and paving the way to net-zero goals
About Xylem
Xylem (XYL) is a leading global water technology company committed to solving the world’s critical water, wastewater, and water-related challenges through technology, innovation, and expertise. Our more than 22,000 diverse employees delivered combined pro forma revenue of $7.3 billion in 2022. We are creating a more sustainable world by enabling our customers to optimize water and resource management and helping communities in more than 150 countries become water-secure. Join us in the effort at www.xylem.com and Let’s Solve Water.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231207154844/en/
Contact information
Houston Spencer
+1 (914) 240-3046
Houston.Spencer@xylem.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press Release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 16:25:00 CEST | Press Release
Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press Release
A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press Release
Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press Release
Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
